Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

HKG/1612 stock hub

HKG/1612 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/1612is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

580.3M

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/1612

In the news

Latest news · HKG/1612

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/E5.4

P25 10.7P50 17.9P75 38.5

ROE17.2

P25 -14.7P50 2P75 9.4

ROIC18.7

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/1612 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

233

Groups with data

Currency

HKD

Showing 233 of 233 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	1,468
Employees Change	140%
Employees Change Percent	10.54
Enterprise value	HKD 515.3M
Exchange	Hong Kong Stock Exchange
Financial currency	HKD
First seen	2026-05-10
Industry	Medical Devices
Isin	KYG9367D1025
Last refreshed	2026-05-10
Market cap	HKD 580.3M
Price	HKD 0.88
Price currency	HKD
Rev Per Employee	635,411.44x
Sector	Healthcare
Sic	3842
Symbol	hkg/1612
Website	https://www.vincentmedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	17.99%
EV Earnings	4.94x
EV/EBIT	3.82x
EV/EBITDA	3.04x
EV/FCF	9.64x
EV/Sales	0.55x
FCF yield	9.22%
P/B ratio	0.86x
P/E ratio	5.44x
P/S ratio	0.62x
PE Ratio10 Y	7.22x
PE Ratio3 Y	4.51x
PE Ratio5 Y	4.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.37%
EBITDA Margin	16.65%
FCF margin	5.73%
Gross margin	35.1%
Gross Profit	HKD 327.4M
Gross Profit Growth	9.21%
Gross Profit Growth Q	19.62%
Gross Profit Growth3 Y	10.8%
Gross Profit Growth5 Y	5.77%
Net Income	HKD 104.4M
Net Income Growth	50.91%
Net Income Growth Q	47.02%
Net Income Growth Quarters	7%
Net Income Growth Years	3%
Net Income Growth3 Y	17.73%
Net Income Growth5 Y	14.27%
Pretax Margin	13.9%
Profit Margin	11.19%
Profit Per Employee	HKD 71,102
Profitable Years	3
ROA	8.01
Roa5y	5.02
ROCE	16.45
ROE	17.25
Roe5y	9.53
ROIC	18.68
Roic5y	13.05

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	128.76%
Cagr3y	32.03%
Cagr5y	-10.1%
Div CAGR3	58.74%
Div CAGR5	-14.59%
EPS Growth	50.51
EPS Growth Q	46.24
EPS Growth Quarters	7
EPS Growth Years	3
EPS Growth3 Y	17.63
EPS Growth5 Y	14.47
FCF Growth3 Y	-10.13%
FCF Growth5 Y	-4.73%
OCF Growth	127.42%
OCF Growth Q	209.64%
OCF Growth10 Y	-2.17%
OCF Growth3 Y	10.62%
OCF Growth5 Y	14.68%
Revenue Growth	16.46x
Revenue Growth Q	15.01x
Revenue Growth Quarters	6x
Revenue Growth Years	3x
Revenue Growth3 Y	8.15x
Revenue Growth5 Y	5.62x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.89
Assets	HKD 1.2B
Cash	HKD 250.9M
Current Assets	HKD 698.8M
Current Liabilities	HKD 357M
Debt	HKD 177.4M
Debt EBITDA	HKD 1.05
Debt Equity	HKD 0.26
Debt FCF	HKD 3.32
Equity	HKD 673.2M
Interest Coverage	149.1
Liabilities	HKD 498.3M
Long Term Assets	HKD 472.7M
Long Term Liabilities	HKD 141.4M
Net Cash	HKD 73.5M
Net Cash By Market Cap	HKD 12.66
Net Cash Growth	-0.46%
Net Debt EBITDA	HKD -0.47
Net Debt Equity	HKD -0.11
Net Debt FCF	HKD -1.37
Tangible Book Value	HKD 655.3M
Tangible Book Value Per Share	HKD 0.99
WACC	6.67

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.96
Inventory Turnover	3.81
Net Working Capital	HKD 130.8M
Quick ratio	1.41
Working Capital	HKD 341.9M
Working Capital Turnover	HKD 2.84

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.27%
Dividend Growth	51.52%
Dividend Growth Years	2%
Dividend per share	HKD 0.05
Dividend Years	10
Dividend Yield	5.91%
Ex Div Date	2026-05-26
Last Dividend	HKD 0.03
Payout Frequency	Semi-Annual
Payout Ratio	25.34%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	128.63%
200-day SMA	0.91
3Y total return	130.19%
50-day SMA	0.94
50-day SMA vs 200-day SMA	50over200
5Y total return	-41.28%
All Time High	3.73
All Time High Change	-76.41%
All Time High Date	2020-07-10
All Time Low	0.3
All Time Low Change	196%
All Time Low Date	2023-06-27
ATR	0.02
Beta	0.79
Beta1y	1.1
Beta2y	0.58
Ch YTD	6.02
High	0.88
High52	1.32
High52 Date	2025-08-25
High52ch	-33.33%
Low	0.87
Low52	0.38
Low52 Date	2025-05-13
Low52ch	128.63%
Ma50ch	-6.3%
Price vs 200-day SMA	-3.7%
RSI	43.91
RSI Monthly	57.39
RSI Weekly	47.56
Sharpe ratio	1.78x
Sortino ratio	4.11
Total Return	5.64%
Tr YTD	6.02
Tr1m	-4.35%
Tr1w	1.15%
Tr3m	-12%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 134M
Operating Income Growth	19.88
Operating Income Growth Q	51.7
Operating Income Growth3 Y	24.15
Operating Income Growth5 Y	13.89
Operating margin	14.37

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	245,303,610%
Net Borrowing	49,390,000
Shares Insiders	4.84%
Shares Institutions	0.02%
Shares Out	659,395,832
Shares Qo Q	0.53%
Shares Yo Y	0.27%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 53.1M
Average Volume	597,000x
Bv Per Share	1.01
CAPEX	HKD -113.6M
Ch1m	-4.35
Ch1w	1.15
Ch1y	114.6
Ch3m	-12
Ch3y	95.56
Ch5y	-57.28
Ch6m	3.53
Change	0%
Change From Open	1.15
Close	0.88
Days Gap	-1.14
Depreciation Amortization	21,318,000
Dollar Volume	269,280
Earnings Date	2026-03-25
EBIT	HKD 134M
EBITDA	HKD 155.3M
EPS	HKD 0.16
F Score	5
FCF	HKD 53.5M
FCF EV Yield	10.38x
FCF Per Share	HKD 0.08
Financing CF	27,341,000
Fiscal Year End	December
Founded	1,997
Graham Number	1.91618
Graham Upside	117.7
Income Tax	HKD 21.3M
Investing CF	-118,463,000
Is Primary Listing	1
Last Earnings Date	2026-03-25
Last Report Date	2025-12-31
Lynch Fair Value	HKD 2.31
Lynch Upside	162.5
Ma150	0.91
Ma150ch	-2.77%
Ma20	0.89
Ma20ch	-1.35%
Net CF	77,432,000
Open	0.87
P FCF Ratio	10.85
P OCF Ratio	3.47
Payment Date	2026-06-18
Position In Range	100
Ppne	385,302,000
Price Date	2026-05-08
Price EBITDA	HKD 3.74
Ptbv Ratio	0.89
Relative Volume	0.49x
Revenue	932,784,000x
SBC By Revenue	0.04x
Share Based Comp	397,000
Tax By Revenue	2.28x
Tax Rate	16.42%
Tr6m	3.53%
Volume	306,000
Z Score	2.65

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

HKG/1612 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.9%

$0.05 annual per share

Payout ratio

+25.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-14.6%

2 consecutive years of growth

Total shareholder yield

+5.6%

Next ex-dividend date: 2026-05-26

Performance

HKG/1612 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/1612?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.0%

Share of float held by funds and institutions

Insider ownership

+4.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.3%

Negative means the company is buying back shares.

Technical

HKG/1612 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.9

Neutral momentum band

Price vs 200-day MA

-3.7%

50/200-day relationship not available

Beta (5Y)

0.79

Less volatile than the market

Sharpe ratio

1.78

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/1612

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/1612 stock rating?

hkg/1612 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/1612 analysis?

The full report lives at /stocks/hkg/1612/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/1612?

The latest report frames hkg/1612 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/1612 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.